Comments
Aurobindo Pharma Ltd has posted a consolidated net profit of Rs 92 crore in the third quarter ended December 31.
The Hyderabad-based company incurred a net loss of Rs 28.5 crore in the year-ago period.
The total revenue increased 22 per cent at Rs 1,570 crore (Rs 1284 crore).
The increase in revenue was driven by 22.5 per cent increase in formulation sales at Rs 912 crore.
“We continue to see traction on our performance both in sales and earnings on year-on-year basis on account of improved business mix in formulations from new product approvals and launches in the US market,’’ N. Govindarajan, Managing Director said in a release.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.